Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema

by Valérie Sarda, Pauline Eymard, Linda Hrarat, Franck Fajnkuchen, Audrey Giocanti-Aurégan
Published 2020-01-01

Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant

by Antoine Herbaut, Franck Fajnkuchen, Lise Qu-Knafo, Sylvia Nghiem-Buffet, Bahram Bodaghi, Audrey Giocanti-Auregan
Published 2017-01-01

Treatment Efficacy and Compliance in Patients with Diabetic Macular Edema Treated with Ranibizumab in a Real-Life Setting

by Anne-Laurence Best, Franck Fajnkuchen, Sylvia Nghiem-Buffet, Typhaine Grenet, Gabriel Quentel, Corinne Delahaye-Mazza, Salomon Y. Cohen, Audrey Giocanti-Aurégan
Published 2018-01-01

Visual Acuity Gain Profiles and Anatomical Prognosis Factors in Patients with Drug-Naive Diabetic Macular Edema Treated with Dexamethasone Implant: The NAVEDEX Study

by Mauricio Pinto, Thibaud Mathis, Pascale Massin, Jad Akesbi, Théo Lereuil, Nicolas Voirin, Frédéric Matonti, Franck Fajnkuchen, John Conrath, Solange Milazzo, Jean-François Korobelnik, Stéphanie Baillif, Philippe Denis, Catherine Creuzot-Garcher, Mayer Srour, Bénédicte Dupas, Aditya Sudhalkar, Alper Bilgic, Ramin Tadayoni, Eric H Souied, Corinne Dot, Laurent Kodjikian
Published 2021-02-01